Skip to content
Menu

Piper Sandler Maintains Overweight on Connect Biopharma Hldgs, Lowers Price Target to $5

Benzinga Newsdesk 2 days ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Piper Sandler analyst Biren Amin maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Overweight and lowers the price target from $7 to $5.

Piper Sandler analyst Biren Amin maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Overweight and lowers the price target from $7 to $5.

Read at benzinga.com